Cranial Electrical Stimulation - Medicare Advantage

This policy addresses cranial electrical stimulation (CES) devices for neuropsychiatric and pain-related conditions — most commonly anxiety, depression, insomnia, fibromyalgia, PTSD, migraines/headaches, and other chronic painful conditions — and notes CES is FDA‑cleared for symptoms of anxiety, depression, and insomnia. Under Medicare Advantage the policy states there are no specific covered indications and, given limited/low‑strength evidence, variable study protocols, and absence of guideline- or CMS‑supported coverage, CES is generally not considered medically reasonable and necessary unless Medicare requirements for coverage are specifically met.

"spinal cord injury or fibromyalgia in another report."

Sign up to see full coverage criteria, indications, and limitations.